CPEX PHARMACEUTICALS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.cpexpharm.com
Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin
- First Posted Date
- 2009-02-24
- Last Posted Date
- 2016-02-15
- Lead Sponsor
- CPEX Pharmaceuticals Inc.
- Registration Number
- NCT00850161
Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus
Phase 2
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- Drug: NasulinOther: Placebo for Nasulin
- First Posted Date
- 2009-02-24
- Last Posted Date
- 2013-12-13
- Lead Sponsor
- CPEX Pharmaceuticals Inc.
- Target Recruit Count
- 94
- Registration Number
- NCT00850096
- Locations
- 🇺🇸
Clinical Research of West Florida, Clearwater, Florida, United States
🇺🇸Rocky Mountain Clinical Research, Idaho Falls, Idaho, United States
🇺🇸Mountain Diabetes and Endocrine Center, Asheville, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath